The Korean Journal of Physiology and Pharmacology

The Korean Society of Pharmacology (대한약리학회)
권호 표지
DOI QR코드

DOI QR Code

NgR1 Expressed in P19 Embryonal Carcinoma Cells Differentiated by Retinoic Acid Can Activate STAT3

  • Received : 2014.10.20
  • Accepted : 2015.01.12
  • Published : 2015.03.30
Download PDF
⟨ Previous Next ⟩

Abstract

NgR1, a Nogo receptor, is involved in inhibition of neurite outgrowth and axonal regeneration and regulation of synaptic plasticity. P19 embryonal carcinoma cells were induced to differentiate into neuron-like cells using all trans-retinoic acid and the presence and/or function of cellular molecules, such as NgR1, NMDA receptors and STAT3, were examined. Neuronally differentiated P19 cells expressed the mRNA and protein of NgR1, which could stimulate the phosphorylation of STAT3 when activated by Nogo-P4 peptide, an active segment of Nogo-66. During the whole period of differentiation, mRNAs of all of the NMDA receptor subtypes tested (NR1, NR2A-2D) were consistently expressed, which meant that neuronally differentiated P19 cells maintained some characteristics of neurons, especially central nervous system neurons. Our results suggests that neuronally differentiated P19 cells expressing NgR1 may be an efficient and convenient in vitro model for studying the molecular mechanism of cellular events that involve NgR1 and its binding partners, and for screening compounds that activate or inhibit NgR1.

Keywords

References

  1. McBurney MW. P19 embryonal carcinoma cells. Int J Dev Biol. 1993;37:135-140.
  2. Canzoniero LM, Sensi SL, Turetsky DM, Finley MF, Choi DW, Huettner JE. Glutamate receptor-mediated calcium entry in neurons derived from P19 embryonal carcinoma cells. J Neurosci Res. 1996;45:226-236. https://doi.org/10.1002/(SICI)1097-4547(19960801)45:3<226::AID-JNR4>3.0.CO;2-F
  3. Grant ER, Errico MA, Emanuel SL, Benjamin D, McMillian MK, Wadsworth SA, Zivin RA, Zhong Z. Protection against glutamate toxicity through inhibition of the p44/42 mitogen-activated protein kinase pathway in neuronally differentiated P19 cells. Biochem Pharmacol. 2001;62:283-296. https://doi.org/10.1016/S0006-2952(01)00665-7
  4. Schwab ME. Functions of Nogo proteins and their receptors in the nervous system. Nat Rev Neurosci. 2010;11:799-811. https://doi.org/10.1038/nrn2936
  5. Wang X, Chun SJ, Treloar H, Vartanian T, Greer CA, Strittmatter SM. Localization of Nogo-A and Nogo-66 receptor proteins at sites of axon-myelin and synaptic contact. J Neurosci. 2002;22:5505-5515. https://doi.org/10.1523/JNEUROSCI.22-13-05505.2002
  6. Liu YY, Jin WL, Liu HL, Ju G. Electron microscopic localization of Nogo-A at the postsynaptic active zone of the rat. Neurosci Lett. 2003;346:153-156. https://doi.org/10.1016/S0304-3940(03)00508-1
  7. Lee H, Raiker SJ, Venkatesh K, Geary R, Robak LA, Zhang Y, Yeh HH, Shrager P, Giger RJ. Synaptic function for the Nogo-66 receptor NgR1: regulation of dendritic spine morphology and activity-dependent synaptic strength. J Neurosci. 2008;28:2753-2765. https://doi.org/10.1523/JNEUROSCI.5586-07.2008
  8. Takei Y. Phosphorylation of Nogo receptors suppresses Nogo signaling, allowing neurite regeneration. Sci Signal. 2009;2: ra14. https://doi.org/10.1126/scisignal.262pe14
  9. Gao Y, Wang B, Xiao Z, Chen B, Han J, Wang X, Zhang J, Gao S, Zhao Y, Dai J. Nogo-66 regulates nanog expression through stat3 pathway in murine embryonic stem cells. Stem Cells Dev. 2010;19:53-60. https://doi.org/10.1089/scd.2008.0357
  10. Wang B, Xiao Z, Chen B, Han J, Gao Y, Zhang J, Zhao W, Wang X, Dai J. Nogo-66 promotes the differentiation of neural progenitors into astroglial lineage cells through mTOR-STAT3 pathway. PLoS One. 2008;3:e1856. https://doi.org/10.1371/journal.pone.0001856
  11. Machida Y, Murai K, Miyake K, Iijima S. Expression of chromatin remodeling factors during neural differentiation. J Biochem. 2001;129:43-49. https://doi.org/10.1093/oxfordjournals.jbchem.a002834
  12. Barrette B, Vallieres N, Dube M, Lacroix S. Expression profile of receptors for myelin-associated inhibitors of axonal regeneration in the intact and injured mouse central nervous system. Mol Cell Neurosci. 2007;34:519-538. https://doi.org/10.1016/j.mcn.2006.12.004
  13. Chen MS, Huber AB, van der Haar ME, Frank M, Schnell L, Spillmann AA, Christ F, Schwab ME. Nogo-A is a myelinassociated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature. 2000;403:434-439. https://doi.org/10.1038/35000219
  14. GrandPre T, Nakamura F, Vartanian T, Strittmatter SM. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature. 2000;403:439-444. https://doi.org/10.1038/35000226
  15. Prinjha R, Moore SE, Vinson M, Blake S, Morrow R, Christie G, Michalovich D, Simmons DL, Walsh FS. Inhibitor of neurite outgrowth in humans. Nature. 2000;403:383-384. https://doi.org/10.1038/35000287
  16. Fournier AE, GrandPre T, Strittmatter SM. Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature. 2001;409:341-346. https://doi.org/10.1038/35053072
  17. Wang KC, Koprivica V, Kim JA, Sivasankaran R, Guo Y, Neve RL, He Z. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature. 2002;417: 941-944. https://doi.org/10.1038/nature00867
  18. Domeniconi M, Cao Z, Spencer T, Sivasankaran R, Wang K, Nikulina E, Kimura N, Cai H, Deng K, Gao Y, He Z, Filbin M. Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth. Neuron. 2002;35:283-290. https://doi.org/10.1016/S0896-6273(02)00770-5
  19. Venkatesh K, Chivatakarn O, Lee H, Joshi PS, Kantor DB, Newman BA, Mage R, Rader C, Giger RJ. The Nogo-66 receptor homolog NgR2 is a sialic acid-dependent receptor selective for myelin-associated glycoprotein. J Neurosci. 2005;25:808-822. https://doi.org/10.1523/JNEUROSCI.4464-04.2005
  20. Ulrich H, Majumder P. Neurotransmitter receptor expression and activity during neuronal differentiation of embryonal carcinoma and stem cells: from basic research towards clinical applications. Cell Prolif. 2006;39:281-300. https://doi.org/10.1111/j.1365-2184.2006.00385.x
  21. Li F, Tsien JZ. Memory and the NMDA receptors. N Engl J Med. 2009;361:302-303. https://doi.org/10.1056/NEJMcibr0902052
  22. Hur SW, Park JM. Long-term potentiation of excitatory synaptic strength in spinothalamic tract neurons of the rat spinal cord. Korean J Physiol Pharmacol. 2013;17:553-558. https://doi.org/10.4196/kjpp.2013.17.6.553
  23. Peng X, Kim J, Zhou Z, Fink DJ, Mata M. Neuronal Nogo-A regulates glutamate receptor subunit expression in hippocampal neurons. J Neurochem. 2011;119:1183-1193. https://doi.org/10.1111/j.1471-4159.2011.07520.x
  24. Kulikov AV, Rzhaninova AA, Goldshtein DV, Boldyrev AA. Expression of NMDA receptors in multipotent stromal cells of human adipose tissue under conditions of retinoic acid-induced differentiation. Bull Exp Biol Med. 2007;144:626-629. https://doi.org/10.1007/s10517-007-0390-6
  25. Dergham P, Ellezam B, Essagian C, Avedissian H, Lubell WD, McKerracher L. Rho signaling pathway targeted to promote spinal cord repair. J Neurosci. 2002;22:6570-6577. https://doi.org/10.1523/JNEUROSCI.22-15-06570.2002
  26. Fournier AE, Takizawa BT, Strittmatter SM. Rho kinase inhibition enhances axonal regeneration in the injured CNS. J Neurosci. 2003;23:1416-1423. https://doi.org/10.1523/JNEUROSCI.23-04-01416.2003
  27. McDonald CL, Bandtlow C, Reindl M. Targeting the Nogo receptor complex in diseases of the central nervous system. Curr Med Chem. 2011;18:234-244. https://doi.org/10.2174/092986711794088326
  28. Willi R, Schwab ME. Nogo and Nogo receptor: relevance to schizophrenia? Neurobiol Dis. 2013;54:150-157. https://doi.org/10.1016/j.nbd.2013.01.011
  29. Lee JY, Petratos S. Multiple sclerosis: does Nogo play a role? Neuroscientist. 2013;19:394-408. https://doi.org/10.1177/1073858413477207

Cited by

  1. All‐trans‐retinoid acid induces the differentiation of P19 cells into neurons involved in the PI3K/Akt/GSK3β signaling pathway vol.121, pp.11, 2015, https://doi.org/10.1002/jcb.29659